Cargando…

Cytokine adsorption during ECMO for COVID-19-related ARDS

Detalles Bibliográficos
Autores principales:	Shekar, Kiran, McAuley, Daniel F, Brodie, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121532/ https://www.ncbi.nlm.nih.gov/pubmed/34000235 http://dx.doi.org/10.1016/S2213-2600(21)00207-1

Ejemplares similares

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases
por: Ramanathan, Kollengode, et al.
Publicado: (2020)

Blood transfusion strategies and ECMO during the COVID-19 pandemic – Authors' reply
por: Ramanathan, Kollengode, et al.
Publicado: (2020)

Cytokine adsorption and ECMO in patients with COVID-19
por: Rybalko, Andrey, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19
por: Nardelli, Pasquale, et al.
Publicado: (2021)

Non-invasive respiratory support strategies in COVID-19
por: Gorman, Ellen, et al.
Publicado: (2021)

Apples and oranges: international comparisons of COVID-19 observational studies in ICUs
por: Millar, Jonathan E, et al.
Publicado: (2020)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

ECMO in COVID-19: do not blame the tool
por: Vuylsteke, Alain
Publicado: (2021)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply
por: Supady, Alexander
Publicado: (2021)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Expert consensus statement on venovenous extracorporeal membrane oxygenation ECMO for COVID-19 severe ARDS: an international Delphi study
por: Rabie, Ahmed A., et al.
Publicado: (2023)

COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions
por: Lascarrou, Jean-Baptiste
Publicado: (2021)

COVID-19 and ECMO: a call for close cooperation and more investigation
por: Lorusso, Roberto, et al.
Publicado: (2021)

Respiratory support before venovenous ECMO for COVID-19: what is the price?
por: Giani, Marco, et al.
Publicado: (2023)

Morbidly obese with severe ARDS: ECMO or no ECMO?
por: Shalaby, Mohammed A.
Publicado: (2017)

Extracorporeal membrane oxygenation (ECMO) and the acute respiratory distress syndrome (ARDS): a systematic review of pre-clinical models
por: Millar, Jonathan E., et al.
Publicado: (2019)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

VV-ECMO in severe COVID-19: multidimensional perspectives on the use of a complex treatment
por: Teijeiro-Paradis, Ricardo, et al.
Publicado: (2023)

ECMO during the COVID-19 pandemic: when is it unjustified?
por: Abrams, Darryl, et al.
Publicado: (2020)

ECMO as an emergency medical countermeasure
por: Paul, Subroto, et al.
Publicado: (2014)

Trends in COVID-19-related in-hospital mortality: lessons learned from nationwide samples
por: Madahar, Purnema, et al.
Publicado: (2021)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

Should we ration extracorporeal membrane oxygenation during the COVID-19 pandemic?
por: Supady, Alexander, et al.
Publicado: (2021)

Real-World Outcomes for ECMO in COVID-19
por: Nurok, Michael, et al.
Publicado: (2022)

RESPIRATORY PHYSIOLOGICAL PARAMETERS AND OUTCOMES OF PATIENTS WITH COVID-19 ARDS AND NON-COVID-19 ARDS UNDERGOING ECMO
por: FEDERBUSH, M., et al.
Publicado: (2022)

What’s new in ECMO for COVID-19?
por: MacLaren, Graeme, et al.
Publicado: (2020)

Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

Hyperoxia during venoarterial ECMO: Culprit or co-variate? A comment from the BLENDER investigators
por: Premraj, Lavienraj, et al.
Publicado: (2022)

ECMO for Critically Ill COVID-19 with ARDS: A Case Series
por: Rai, D., et al.
Publicado: (2021)

Pharmacological treatments in ARDS; a state-of-the-art update
por: Boyle, Andrew James, et al.
Publicado: (2013)

ECMO in severe acute respiratory distress syndrome
por: Matthay, Michael A
Publicado: (2019)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

To prone or not to prone ARDS patients on ECMO
por: Roca, Oriol, et al.
Publicado: (2021)

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS
por: Shetty, Ashok K., et al.
Publicado: (2021)

Do Nonventilatory Strategies for Acute Lung Injury and ARDS Work?
por: Sweeney, Rob Mac, et al.
Publicado: (2010)

Galectin-3 Inhibition in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2022)

The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology
por: Millar, Jonathan E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gv4cojcb9riaju8s23p174q4he